statistiche ricercatore

MORTARA, LORENZO

Distribuzione geografica

Continente	#
EU - Europa	12.677
NA - Nord America	10.992
AS - Asia	2.302
Continente sconosciuto - Info sul continente non disponibili	16
OC - Oceania	16
SA - Sud America	15
AF - Africa	9
Totale	26.027

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	10.973
IT - Italia	7.864
UA - Ucraina	1.784
TR - Turchia	778
SE - Svezia	659
CN - Cina	570
VN - Vietnam	556
DE - Germania	529
IE - Irlanda	479
FI - Finlandia	458
FR - Francia	401
SG - Singapore	257
GB - Regno Unito	202
IN - India	57
NL - Olanda	54
JP - Giappone	45
BE - Belgio	39
CH - Svizzera	32
CZ - Repubblica Ceca	28
ES - Italia	28
AT - Austria	17
PL - Polonia	16
CA - Canada	15
EU - Europa	14
AU - Australia	12
BR - Brasile	11
NO - Norvegia	10
RO - Romania	10
RU - Federazione Russa	10
PT - Portogallo	9
PK - Pakistan	6
GR - Grecia	5
HK - Hong Kong	5
MD - Moldavia	5
TH - Thailandia	5
BG - Bulgaria	4
HU - Ungheria	4
NZ - Nuova Zelanda	4
DK - Danimarca	3
EE - Estonia	3
ID - Indonesia	3
IL - Israele	3
IQ - Iraq	3
IR - Iran	3
LT - Lituania	3
LU - Lussemburgo	3
MK - Macedonia	3
MX - Messico	3
NG - Nigeria	3
RS - Serbia	3
SK - Slovacchia (Repubblica Slovacca)	3
A2 - ???statistics.table.value.countryCode.A2???	2
AR - Argentina	2
CL - Cile	2
EG - Egitto	2
MC - Monaco	2
MT - Malta	2
PH - Filippine	2
SC - Seychelles	2
TN - Tunisia	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
BA - Bosnia-Erzegovina	1
BD - Bangladesh	1
CY - Cipro	1
GL - Groenlandia	1
HR - Croazia	1
KW - Kuwait	1
KZ - Kazakistan	1
LI - Liechtenstein	1
LV - Lettonia	1
MY - Malesia	1
NP - Nepal	1
SA - Arabia Saudita	1
TW - Taiwan	1
Totale	26.027

Salva come PNG Salva come JPEG

Città	#
Milan	4.222
Jacksonville	1.342
Chandler	1.254
Fairfield	1.025
Woodbridge	773
Ashburn	633
Ann Arbor	629
Houston	517
Princeton	491
Dublin	472
Wilmington	456
Dearborn	421
Izmir	400
Nyköping	379
Rome	371
Boardman	354
Seattle	345
Como	320
Cambridge	317
Dong Ket	314
Singapore	236
Beijing	173
San Mateo	162
New York	97
San Diego	95
Kocaeli	93
Chicago	85
Ogden	84
Turin	67
Los Angeles	56
Helsinki	52
Hefei	50
Santa Clara	48
Verona	48
Dallas	47
Florence	46
London	40
Düsseldorf	39
Kunming	39
Nanjing	39
Brussels	37
Munich	37
Tokyo	36
Genoa	34
Washington	33
Jinan	32
Norwalk	29
Brno	23
Guangzhou	23
Berlin	21
Pune	21
Bari	20
Bologna	20
Redmond	20
Frankfurt am Main	18
Varese	18
Naples	16
Brescia	15
Magnago	15
Nanchang	14
Parma	14
Shenyang	14
Venice	13
Fuzhou	12
Siena	12
Garbagnate Milanese	11
Modena	11
Reggio Emilia	11
Changsha	10
Chengdu	10
Gorgonzola	10
Padova	10
Ponte Lambro	10
West Jordan	10
Hebei	9
Monza	9
Palermo	9
Redwood City	9
Treviso	9
Trieste	9
Vienna	9
Budrio	8
Paris	8
Stockholm	8
Taranto	8
Edinburgh	7
Graz	7
Lausanne	7
Perugia	7
Philadelphia	7
Ravenna	7
Rozzano	7
Vicenza	7
Zurich	7
Auburn Hills	6
Bolzano	6
Cagliari	6
Lappeenranta	6
Pittsburgh	6
Quzhou	6
Totale	17.465

Salva come PNG Salva come JPEG

Nome	#
Allergie e intolleranze. Icone di immunopatologia.	2.451
Natural killer cells from patients with malignant or inflammatory pleural effusions display decreased cytotoxicity and decidual NK-like phenotype	215
Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer	204
Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?	195
Can the co-dependence of the immune system and angiogenesis facilitate pharmacological targeting of tumours?	187
Grading of laboratories on CD4+T-lymphocyte evaluations based on acceptable data boundaries defined by the measurement error	186
Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells	183
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response	170
DC-SIGN from African green monkeys is expressed in lymph nodes and mediates infection in trans of simian immunodeficiency virus (SIVagm)	165
Natural killer cells as key players of tumor progression and angiogenesis: old and novel tools to divert their pro-tumor activities into potent anti-tumor effects	164
Orchestration of angiogenesis by immune cells	163
CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4(+) T lymphocytes for immunotherapy	161
Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.	160
Recognition of antigenic clusters of Candida albicans by T lymphocytes from human immunodeficiency virus-infected persons.	159
Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization	159
Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review	159
Positive role of macaque cytotoxic T lymphocytes during SIV infection: decrease of cellular viremia and increase of asymptomatic clinical period.	158
The therapeutic T-cell response induced by tumor delivery of TNF and melphalan is dependent on early triggering of natural killer and dendritic cells	158
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS	157
The human RNASET2 protein affects the polarization pattern of human macrophages in vitro	156
Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication	155
Proffered Paper: The pro-angiogenic phenotype of natural killer cells infiltrating squamous cell carcinoma lung cancer	155
Natural killer cells from patients with either malignant or inflammatory pleural effusions display decreased cytotoxic capacity and decidual-like phenotype	152
Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies	152
Myeloid derived suppressor cells interactions with natural killer cells and pro-angiogenic activities: roles in tumor progression	151
New strategies of mammary cancer vaccination	150
CD56(bright)CD16(-) NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4(+) T Cell Proliferation	149
CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions.	148
The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer	147
Schedule-dependent therapeutic efficacy of L19mTNF-a and Melphalan combined with Gemcitabine	147
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection and specific anti-tumor memory.	145
Tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells: a new paradigm in colorectal cancer angiogenesis	141
Early DC and NK cell activation during anticancer therapeutic response induced by TNFa tumor vessel delivery and melphalan	140
Recognition of human T Leukaemia virus (HTLV-I) envelope by human CD4+ T cell lines from HTLV-I seronegative individuals: specificity and clonal heterogeneity.	138
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific anti-tumor memory	136
Selection of virus variants and emergence of virus escape mutants after immunization with epitope vaccine	135
Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: Implications for immunotherapy	133
Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent antitumor preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions.	132
Acetyl-L-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways	129
T2 ribonuclease-mediated tumor suppression: an evolutionary conserved process involving a cross-talk between cancer cells and the immune system	128
Tumor Vasculature Targeted TNFα Therapy: Reversion of Microenvironment Anergy and Enhancement of the Anti-tumor Efficiency.	127
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a TH1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory	125
Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene	125
Type 1 CD4+ T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptide vaccine in rhesus macaques.	124
Down syndrome, autoimmunity and T regulatory cells	122
Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy	121
Plasmocytoid dendritic cell dynamics and alpha IFN production during Simian Immunodeficiency Virus infection with a nonpathogenic outcome	120
Analysis of the antigen specific T cell repertoire in HIV infection	117
Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent antitumor preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions	114
CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapy	112
The pro-angiogenic phenotype and functions of colorectal cancer tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells	112
Early triggering of natural killer and dendritic cell during antitumor therapeutic response induced by TNFa tumor vessel delivery and melphalan	111
Therapy-induced antitumor vaccination by targeting tumor necrosis factor  to tumor vessels in combination with melphalan	110
Targeted delivery of TNF-alpha to tumor vessels induces a strong cell-mediated immune response against homologous and heterologous tumors.	109
Microenvironment-mediated regulation of cancer growth by the human RNASET2 oncosuppressor gene	109
Inhibition of Human T-Cell Leukemia virus type 2 (HTLV-2) replication by the suppressive action of CIITA and NF-Y	108
Phenotypic and functional characterization of tumor infiltrating natural killer cells: role in tumor angiogenesis	107
Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors	107
Antitumor vaccines and immunotherapeutic strategies based on CIITA-driven MHC class II espression in cancer cells.	106
Polarization of Tumor Infiltrating Leukocytes from Innate Immunity and their role in the Pro-angiogenic Phenotype in NSCLC	105
Inflammation, inflammatory cells and angiogenesis: decisions and indecisions	104
Tumor infiltrating (TINKs) and tumor associated (TANKs) from colorectal cancer patients are proangiogenic and express angiogenin and the MMP9-TIMP2, similar to decidual NK cells	104
Regulation of macrophage differentiation and polarization pattern by human RNASET2 protein	104
Tumor rejection and anti-tumor memory to neoplasias of different histotype genetically modified to express CIITA- autologous MHC class II genes. A new strategy of anti-tumor vaccination and tumor immunotherapy.	103
Prostate cancer peripheral blood NK cells show enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 production, and secrete monocyte-recruiting and polarizing factors.	103
Phenotype and function of myeloid dendritic cells derived from African green monkey blood monocytes	102
Tumor treatment by TNF-alpha targeted to tumor vessels and melphalan induces strong adaptive immune response, protection from tumor growth and anti-tumor memory.	102
Early functional activation of natural killer cell and dendritic cell during the antitumor therapeutic response induced by TNFa tumor vessel delivery and melphalan	102
Natural killer cells from malignant pleural effusion show a decidual-like phenotype and an alternative activatory state.	102
Severità del Morbo di Basedow di prima diagnosi: ruolo dei linfociti Treg e dei micronutrienti. Dati preliminari di uno studio osservazionale pilota	102
A new strategy of tumor vaccination based on mammary adenocarcinoma cells transduced with the MHC class II transactivator CIITA	101
Natural killer cells infiltrating colo-rectal cancer are switched towards the decidual-like pro-angiogenic CD56brightCD16- NK cell subset	101
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation	101
Tumor targeted IL-2 and TNF alpha trigger a synergistic T cell-mediated therapeutic effect against mouse neuroblastoma.	100
Tumor-infiltrating (TINKs) and tumor-associated (TANKs) natural killer cells: a new player in the inflammatory orchestration of tumor angiogenesis in colon cancer	100
The rnaset2 oncosuppressor protein regulates both differentiation and polarization in human macrophages	100
Analyse de DC-SIGN dans un modèle de résistance au SIDA	99
STAT3 and STAT5 drive the pro-angiogenic NK cell polarization in colorectal cancer patients	98
Phenotypic and functional characterization of tumor infiltrating natural killer cells: role in tumor angiogenesis	97
Analysis of Graves’ disease from the origins to the recent historical evolution	97
Therapy-induced antitumor vaccination by targeting TNFa to tumor vessels in combination with melphalan	96
Natural killer cells from pleural effusions are responsive to interleukin-2 but are endowed with a potent pro-angiogenic feature	96
Sequential Immunogene Therapy with Interleukin-12- and Interleukin-15-Engineered Neuroblastoma Cells Cures Metastatic Disease in Syngeneic Mice.	95
Innate immunity driving tumor angiogenesis: the role of natural killer cells in non-small cell lung cancer (NSCLC)	95
The challenge of prognostic markers in pleural mesothelioma	95
The MHC class II transactivator (CIITA): a "physiologic" drug against HIV-1 replication	94
Functional and phenotypic characterization of tumor infiltrating NK cells.	93
TPA-mediated down-regulation of MHC class II gene expression in human macrophage precursors by destabilization of the MHC-II transactivator (CIITA) mRNA	93
Impact of SIV lipopeptide vaccination on survival of macaques: major role of CTL responses on delaying onset of AIDS	92
Experimental therapeutic approaches to adenocarcinoma: the potential of tumor cells engineered to express MHC class-II molecules combined with naked DNA interleukin-12 gene transfer	92
CIITA-driven MHC-II+ tumor cells: preventive vaccines and superior generators of anti-tumor CD4+ T lymphocytes for immunotherapy.	92
Analysis of the selection pressure by the NEF-immunodominant macaque CTL response in SIV infection	92
Natural killer cells from malignant pleural effusion are switched toward an NK proangiogenic polarization	92
VEGFR2 and CXCR4 pathways are modulated by acetyl-l-Carnitine that acts as an anti-angiogenic agent	92
Functional and phenotypic characterization of tumor infiltrating NK cells to identify novel targets for anticancer therapy.	92
Early induction of an anti-inflammatory environment during primary SIVagm infection	91
In vivo containment of SIV replication associated with induction of broad multispecific cytotoxic T lymphocytes directed against conserved viral epitopes	91
Fine characterization of macaque cytotoxic T lymphocytes (CTL) induced by lipopeptides into rhesus macaques. Optimization of lipopeptide immunization to induce multispecific CTL	91
The oncosuppressive role of RNASET2 gene in a mouse tumor syngeneic model	91
NK cells as modulators of tumor angiogenesis	90
Totale	14.741

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	92.010
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	92.010

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	2.646	0	0	0	0	121	384	673	524	223	330	101	290
2020/2021	3.310	54	320	98	306	100	330	129	294	567	282	315	515
2021/2022	2.479	306	286	212	113	100	56	134	165	213	317	220	357
2022/2023	3.904	335	198	250	412	267	774	60	487	521	189	203	208
2023/2024	7.392	1.081	1.086	1.114	1.210	1.244	513	132	168	216	246	177	205
2024/2025	1.675	152	177	785	318	243	0	0	0	0	0	0	0
Totale													26.325